Oppenheimer, S. M., et al. “Lateral Hypothalamic Area Neurotransmission and Neuromodulation of the Specific Cardiac Effects of Insular Cortex Stimulation”. Brain Research, vol. 581, no. 1, 1992, pp. 133-42, https://doi.org/10.1016/0006-8993(92)90352-a.

Genre

  • Journal Article
Contributors
Author: Oppenheimer, S. M.
Author: Saleh, T. M.
Author: Cechetto, D. F.
Date Issued
1992
Abstract

Microstimulation of the rat posterior insular cortex in phase with the ECG R wave elicits pure cardiac effects unaccompanied by changes in blood pressure or respiration. This technique has successfully demonstrated cardiac chronotropic organisation and arrhythmogenesis within the insula. Pathways exist linking the insular cortex with the lateral hypothalamic area (LHA). Similarly, the LHA has previously been shown to mediate the sympathetic and blood pressure effects of insular cortex stimulation. Therefore it was anticipated that the tachycardia elicited by insular phasic microstimulation would be responsive to LHA manipulations. Insular tachycardia sites in 28 chloralose-anesthetised male Wistar rats were phasically stimulated once with each cardiac cycle using 500 microA for 1 min before and after microinfusions (390 nl) into the LHA. The insular tachycardia response was abolished by LHA microinfusions of the synaptic blocker cobaltous chloride (4 mM). LHA microinjection of kynurenic acid (250 mM) attenuated insular tachycardia by 95%. Microinjection of naloxone (30 mM) similarly attenuated the tachycardia by 95%. Met-enkephalin (3.5 mM) was without effect on this response whereas Leu-enkephalin (3.5 mM) and neuropeptide Y (0.01 mM) (NPY) doubled the magnitude of the tachycardia. Dynorphin (0.12 mM), a specific kappa opioid receptor agonist, augmented the response to stimulation of insular tachycardia sites 8-fold. Consequently, it is suggested that the LHA contains an obligatory synapse mediating insular tachycardia and that glutamate is the likely neurotransmitter at this site. Neuromodulation of insular tachycardia may be effected by opiate kappa and NPY receptors, a finding of considerable clinical relevance.

Note

Department of Stroke and Aging, John P. Robarts Research Institute, London, Ont., Canada.

NETHERLANDS

ID: 1460; LR: 20061115; JID: 0045503; 0 (Neuropeptide Y); 492-27-3 (Kynurenic Acid); 58569-55-4 (Enkephalin, Methionine); 58822-25-6 (Enkephalin, Leucine); 7440-48-4 (Cobalt); 74913-18-1 (Dynorphins); ppublish

Source type: Electronic(1)

Language

  • English

Subjects

  • animals
  • Heart Rate/drug effects/physiology
  • Rats, Inbred Strains
  • Enkephalin, Leucine/pharmacology
  • Electrocardiography/drug effects
  • Male
  • Cobalt/pharmacology
  • Dynorphins/pharmacology
  • Rats
  • Electric Stimulation
  • Cerebral Cortex/physiology
  • Enkephalin, Methionine/pharmacology
  • Hypothalamic Area, Lateral/drug effects/physiology
  • Synaptic Transmission/drug effects/physiology
  • Kynurenic Acid/pharmacology
  • Neuropeptide Y/pharmacology
  • Heart/drug effects/innervation
Page range
133-142
Host Title
Brain Research
Host Abbreviated Title
Brain Res.
Volume
581
Issue
1
ISSN
0006-8993

Department